WO2024085820 - A PACKAGING TECHNIQUE FOR DRY POWDER INHALER
National phase entry is expected:
Publication Number
WO/2024/085820
Publication Date
25.04.2024
International Application No.
PCT/TR2022/051169
International Filing Date
21.10.2022
Title **
[English]
A PACKAGING TECHNIQUE FOR DRY POWDER INHALER
[French]
TECHNIQUE D'EMBALLAGE POUR INHALATEUR DE POUDRE SÈCHE
Applicants **
ARVEN ILAC SANAYI VE TICARET ANONIM SIRKETI
Inventors
KAYA, Tansel
CELIK, Devrim
YILMAZ, Emine
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
Turkpatent
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2055 | |
| EPO | Filing, Examination, Granting | 9702 | |
| Japan | Filing, Examination, Granting | 2212 | |
| South Korea | Filing, Examination, Granting | 2080 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
20,789
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
This invention is about a packaging technique for dry powder inhaler comprising a blister having a layer of polymeric materials and an aluminum folio layer superposed to the layer of the polymeric material and having at least one cavity that is used for storing an inhalable formulation is in the volume range of 32 to 60 mm3 and the cavity is filled up to 25-100% wherein the inhalable composition is comprising one or more active agent, which is selected from the group consisting of short-acting β2 agonists (SABAs), long-acting β2 agonists (LABAs), ultra-long acting β2 agonists, long-acting muscarinic antagonists (LAMAs), non-selective dopamine agonist and corticosteroids or a pharmaceutically acceptable salt thereof, in characterizing that a pouch is surrounding an inhaler device equipped with the blister in a vacuum-sealed manner.[French]
La présente invention concerne une technique d'emballage pour inhalateur de poudre sèche comprenant un blister ayant une couche de matières polymères et une couche de feuille d'aluminium superposée sur la couche de la matière polymère et ayant au moins une cavité qui est utilisée pour stocker une formulation inhalable et qui est dans la plage de volume de 32 à 60 mm3, la cavité étant remplie jusqu'à 25-100 %, la composition inhalable comprenant un ou plusieurs agents actifs, qui sont choisis dans le groupe constitué par des agonistes β2 à action courte (SABA), des agonistes β2 à action prolongée (LABA), des agonistes β2 à action ultra-longue, des antagonistes muscariniques à action prolongée (LAMA), un agoniste de dopamine non sélectif et des corticostéroïdes ou un sel pharmaceutiquement acceptable de ceux-ci, caractérisée en ce qu'une poche entoure un dispositif inhalateur équipé du blister d'une manière scellée sous vide.